Tuesday, July 22, 2014 Last update: 12:33 AM
FreshNews.com - All Company Technology News Since 1996

Dicerna to Present at Two Upcoming Conferences

Companies mentioned in this article: Dicerna Pharmaceuticals, Inc.

WATERTOWN, Mass. -- (BUSINESS WIRE) -- Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), a leader in the development of RNAi-based therapeutics, today announced that members of the management team will present at two upcoming conferences:

  • Bernstein Emerging Biotech Conference 2014, Snowbird, Utah: Douglas M. Fambrough, Ph.D., Chief Executive Officer, to present on Tuesday, March 11, 2014 at 5:40 P.M.
  • BIO-Europe Spring® 2014 Conference in Turin, Italy: James B. Weissman, Chief Business Officer, to participate in a panel discussion titled, “Dealmaking strategies around orphan diseases,” on Monday, March 10 at 1:30 P.M. and to present on Tuesday, March 11 at 4:45 P.M.

About Dicerna Pharmaceuticals, Inc.

Dicerna is a biopharmaceutical company focused on the discovery and development of innovative treatments for rare inherited diseases involving the liver and for cancers that are genetically defined. Dicerna is using its proprietary RNA interference (RNAi) technology platform to build a broad pipeline in these therapeutic areas and intends to discover, develop and commercialize novel therapeutics either on its own or in collaboration with pharmaceutical partners.


Copyright © Business Wire 2014
Contact:

Company:
Dicerna Pharmaceuticals, Inc.
James B. Weissman, 617-621-8097
Chief Business Officer
or
Media:
MacDougall Biomedical Communications
Chris Erdman, 781-235-3060
Senior Vice President
chris@macbiocom.com